اليوم السابع
اليوم السابع
Ready to play
Ready to play
The Egyptian Drug Authority has confirmed that there is no decision to stop importing or trading any type of insulin preparations in the Egyptian market. All current registered and available products continue to be accessible, with efforts focused on ensuring the sustainability of their supplies to meet the needs of diabetic patients. The government’s policy regulation regarding insulin supply aims to encourage reliance on local alternatives, which have now developed sufficient manufacturing capabilities, without affecting import freedom or weakening the availability of imported medicines. The local manufacturing strategy is considered important for enhancing production capacity and reducing dependence on external supply chains, while ensuring that all products comply with regulatory and quality standards.
Notice: This Is an AI-Generated Summary
Comments (0)